1. EachPod
EachPod

65. Meredith Cummins - CEO of Neuroendocrine Cancer Australia

Author
Michael Fernando and Josh Hurwitz
Published
Sat 30 Sep 2023
Episode Link
https://shows.acast.com/oncology-for-the-inquisitive-mind/episodes/6517aaa82843410011b6ab7b

It is frequently said that it takes a village to treat a patient with cancer. However, beyond the nuts and bolts of medical and allied health treatment, there exists a whole other world of advocacy and education. Charitable and not-for-profit foundations, both nationally and internationally, have done incredible work for many years in raising awareness and funding for cancer treatment and prevention, as well as providing both patient- and doctor-centred education. Oncology for the Inquisitive Mind is incredibly privileged to welcome the CEO of one such organisation, Meredith Cummins of Neuroendocrine Cancer Australia. Meredith brings decades of experience in oncology nursing, governance, fundraising and advocacy, and has done invaluable work in shining a light on the lesser-known challenges facing patients and doctors dealing with neuroendocrine cancers.


Links from this episode:

Neuroendocrine Cancer Australia: https://neuroendocrine.org.au/

PLANET registry: https://neuroendocrine.org.au/planetregistry/

COMPOSE study information: https://trials.cancervic.org.au/details.aspx?ID=feed-cta-trial444

MoST framework: https://www.rarecancers.org.au/page/105/molecular-screening-and-therapeutics-most-#:~:text=MoST%20is%20a%20two%20part,treatments%20and%20new%20drug%20combinations.


For more episodes, resources and blog posts, visit www.inquisitiveonc.com

Please find us on Twitter @InquisitiveOnc!

If you want us to look at a specific trial or subject, email us at [email protected]


Art courtesy of Taryn Silver

Music courtesy of Music Unlimited: https://pixabay.com/users/music_unlimited-27600023/


Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.


Hosted on Acast. See acast.com/privacy for more information.

Share to: